[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522810":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":27,"locations":32,"responsibleParty":143,"collaborators":18,"id":145,"slug":18,"hasResults":146,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":150,"eligibilityCriteria":151,"healthyVolunteers":146,"sex":152,"minAge":153,"maxAge":18,"enrollmentInfo":154,"targetDuration":18,"studyType":157,"phases":158,"briefSummary":161,"conditions":162,"keywords":18,"overallStatus":35,"whyStopped":18,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":167,"startDateStruct":170,"completionDateStruct":172,"leadSponsor":174,"locationsCount":175},{"fullName":5,"class":6},"Perceive Biotherapeutics, Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"VOY-101","EXPERIMENTAL","Single intravitreal injection of VOY-101",[13],"Biological: VOY-101",{"label":15,"type":16,"description":17,"interventionNames":18},"Controll","NO_INTERVENTION","Fellow Eye",null,[20],{"type":21,"name":9,"description":9,"armGroupLabels":22,"otherNames":18},"BIOLOGICAL",[9],[24],{"name":25,"affiliation":5,"role":26},"Anne Fung, MD","STUDY_DIRECTOR",[28],{"name":25,"role":29,"phone":30,"phoneExt":18,"email":31},"CONTACT","(800) 867-7960","Voy101clinical@perceivebio.com",[33,46,56,65,74,84,93,103,115,125,134],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":18},"Retina Macula Institute of AZ","RECRUITING","Scottsdale","Arizona","85255","United States",{"type":41,"coordinates":42},"Point",[43,44],-111.89903,33.50921,{"lat":44,"lon":43},{"facility":47,"status":35,"city":48,"state":49,"zip":50,"country":39,"cosmosGeoPoint":51,"geoPoint":55,"contacts":18},"The Retina Partners","Encino","California","91436",{"type":41,"coordinates":52},[53,54],-118.50119,34.15917,{"lat":54,"lon":53},{"facility":57,"status":35,"city":58,"state":49,"zip":59,"country":39,"cosmosGeoPoint":60,"geoPoint":64,"contacts":18},"Retinal Consultants Medical Group","Sacramento","95825",{"type":41,"coordinates":61},[62,63],-121.4944,38.58157,{"lat":63,"lon":62},{"facility":66,"status":35,"city":67,"state":49,"zip":68,"country":39,"cosmosGeoPoint":69,"geoPoint":73,"contacts":18},"Retina Consultants San Diego","San Diego","92064",{"type":41,"coordinates":70},[71,72],-117.16472,32.71571,{"lat":72,"lon":71},{"facility":75,"status":35,"city":76,"state":77,"zip":78,"country":39,"cosmosGeoPoint":79,"geoPoint":83,"contacts":18},"Star Retina","Burleson","Texas","76028",{"type":41,"coordinates":80},[81,82],-97.32085,32.54208,{"lat":82,"lon":81},{"facility":85,"status":35,"city":86,"state":77,"zip":87,"country":39,"cosmosGeoPoint":88,"geoPoint":92,"contacts":18},"Retina Center of Texas","Southlake","76092",{"type":41,"coordinates":89},[90,91],-97.13418,32.94124,{"lat":91,"lon":90},{"facility":94,"status":35,"city":95,"state":96,"zip":97,"country":39,"cosmosGeoPoint":98,"geoPoint":102,"contacts":18},"University of Utah John A. Moran Eye Center","Salt Lake City","Utah","84132",{"type":41,"coordinates":99},[100,101],-111.89105,40.76078,{"lat":101,"lon":100},{"facility":104,"status":105,"city":106,"state":107,"zip":108,"country":109,"cosmosGeoPoint":110,"geoPoint":114,"contacts":18},"Sydney Retina Clinic and Day Surgery","ACTIVE_NOT_RECRUITING","Sydney","New South Wales","2000","Australia",{"type":41,"coordinates":111},[112,113],151.20732,-33.86785,{"lat":113,"lon":112},{"facility":116,"status":105,"city":117,"state":118,"zip":119,"country":109,"cosmosGeoPoint":120,"geoPoint":124,"contacts":18},"Cerulea Clinical Trials","East Melbourne","Victoria","3002",{"type":41,"coordinates":121},[122,123],144.9879,-37.81667,{"lat":123,"lon":122},{"facility":126,"status":35,"city":127,"state":18,"zip":18,"country":128,"cosmosGeoPoint":129,"geoPoint":133,"contacts":18},"Rambam Medical Center","Haifa","Israel",{"type":41,"coordinates":130},[131,132],34.99928,32.81303,{"lat":132,"lon":131},{"facility":135,"status":35,"city":136,"state":18,"zip":137,"country":128,"cosmosGeoPoint":138,"geoPoint":142,"contacts":18},"Tel-Aviv Sourasky Medical Center, Ophthalmology Division","Tel Aviv","64239",{"type":41,"coordinates":139},[140,141],34.78057,32.08088,{"lat":141,"lon":140},{"type":144,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100522810",false,"NCT06087458","Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration","Phase 1\u002F2a Dose Escalation Study of VOY-101 in Patients With Advanced Non- Neovascular Age-Related Macular Degeneration","JOURNEY","Inclusion Criteria:\n\n* Are ≥60 years of age at the time of consent.\n* Are willing and able to understand and provide written informed consent.\n* Are willing and able to return for scheduled treatment and follow-up examinations.\n* Are able to undergo ETDRS BCDVA testing and ophthalmic imaging.\n* Well-demarcated GA secondary to AMD in the absence of MNV and in the absence of history of MNV for both eyes.\n* Absence of signs of non-exudative MNV.\n* Additional Ocular Inclusion Criteria for both eyes.\n* Meet certain genotype criteria for risk of AMD.\n\nExclusion Criteria:\n\n* Are women of childbearing potential (WOCBP) and are pregnant or unwilling to use and document use of effective contraception for the duration of the study.\n* Additional Systemic, Ocular, and Genetic Exclusion Criteria.","ALL","60 Years",{"count":155,"type":156},60,"ESTIMATED","INTERVENTIONAL",[159,160],"PHASE1","PHASE2","The Phase 1 safety study of VOY-101 comprises of escalating dose Cohorts, followed by a Phase 2a.",[163,164,165],"Age-Related Macular Degeneration","Geographic Atrophy","Non-neovascular AMD","2025-10-13",{"date":168,"type":169},"2025-10-15","ACTUAL",{"date":171,"type":169},"2023-06-21",{"date":173,"type":156},"2028-03",{"name":5,"class":6},11]